Fort P, Lifshitz F, Bellisario R, Davis J, Lanes R, Pugliese M, Richman R, Post E M, David R
J Pediatr. 1984 Apr;104(4):545-9. doi: 10.1016/s0022-3476(84)80544-2.
We describe 12 of 1130 infants with Down syndrome in whom various degrees of thyroid dysfunction were detected by neonatal screening. These aberrations were confirmed subsequently in 11 patients. In eight of 11 children, persistent primary hypothyroidism, was diagnosed, whereas in the remaining three patients transient thyroid abnormalities were noted. The twelfth patient died and could not be retested. We found an incidence of persistent primary congenital hypothyroidism in infants with Down syndrome of 1:141, or about 28 times more than in the general population. The cause of thyroid aberrations in these infants remains unclear; none of the studied patients had agenesis or ectopia of the thyroid gland. On initial screening most infants with Down syndrome had only mild biochemical abnormalities, with gradual decompensation occurring thereafter. Infants with Down syndrome are therefore at high risk for congenital hypothyroidism and should have careful follow-up to prevent further deterioration of their mental development or growth.
我们描述了1130例唐氏综合征婴儿中的12例,这些婴儿通过新生儿筛查检测出不同程度的甲状腺功能障碍。随后在11例患者中证实了这些异常。在11名儿童中的8名中,诊断为持续性原发性甲状腺功能减退,而其余3名患者则出现短暂性甲状腺异常。第12例患者死亡,无法重新检测。我们发现唐氏综合征婴儿中持续性原发性先天性甲状腺功能减退的发病率为1:141,约为普通人群的28倍。这些婴儿甲状腺异常的原因尚不清楚;所研究的患者均无甲状腺缺如或异位。在初次筛查时,大多数唐氏综合征婴儿仅有轻度生化异常,此后逐渐失代偿。因此,唐氏综合征婴儿患先天性甲状腺功能减退的风险很高,应进行仔细随访,以防止其智力发育或生长进一步恶化。